Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of β-lapachone derivative and its preparation method and medical application

A technology of derivatives and compounds, applied in the field of β-lapachone derivatives, to achieve the effect of novel structure, simple operation and good selectivity

Active Publication Date: 2018-01-30
XINXIANG MEDICAL UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The innovation of the present invention lies in the synthesis of a hybrid of β-lapachone and pyrimidinethione, which has not yet been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of β-lapachone derivative and its preparation method and medical application
  • A kind of β-lapachone derivative and its preparation method and medical application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Synthesis of Example 1 Compound

[0021] Under argon protection, the compound 4-amino-3-(aminoethyl)naphthalene-1-phenol (940 mg, 5.0 mmol) was dissolved in 20 mL of dichloromethane, and the solution was cooled to 0 in an ice bath. ℃. A solution of thiocarbonyldiimidazole (978 mg, 5.5 mmol) dissolved in 20 mL of dichloromethane was added dropwise within 10 minutes. After the addition was completed, the temperature was raised to room temperature and reacted for 5 hours. After the completion of the reaction, the solvent was evaporated and washed with a small amount of ethanol to obtain the corresponding light yellow solid. Add 20mL of acetone to dissolve, and cool the solution to 0°C in an ice bath. Will be dissolved in 200 mL of 0.06 M NaH 2 PO 4 3.34 g of Fermi salt was added dropwise to the reaction solution, the temperature was controlled below 10 ℃ to react for 2 hours, filtered and washed with water to obtain 538 mg of orange-yellow red solid I, with a yield of 32%. ...

Embodiment 2

[0023] Example 2 In vitro anti-tumor activity test

[0024] The MTT method was used to test the anti-tumor activity of the target compound. Human liver cancer cell HepG2 was used as the test cell line. Adherent tumor cells in logarithmic growth phase were selected, and after trypsinization, they were prepared into a cell suspension of 5000 cells / mL with RPMI 1640 medium containing 10% calf serum. Inoculate in 96-well culture plate, inoculate 200 μL per well, 37 ℃, 5% CO 2 Cultivate for 24 hours. Set up a negative control group, a positive control group and a drug-administered group. The experimental group was replaced with a new medium containing different concentrations of the tested samples, the control group was replaced with a medium containing an equal volume of solvent, and the positive control group was given the positive control drug adriamycin (diluted with complete medium to a concentration of 10 μmol·L) - 1 ), each group has 3-5 parallel holes, 37 ℃, 5% CO 2 Cultiva...

Embodiment 3

[0025] Example 3 NQO1 activity test

[0026] The 1 mL reaction system contains 25 mM Tris / HCl (pH 7.4), 0.7 mg / mL bovine serum albumin, 0.1% Tween-20, 200 μM NADH, 77 μM Cytochrome c, 2 μg recombinant human NQOl and 1, 2 ,3,4-Tetrahydro-2-thiobenzo[ h ] Quinazoline-5,6-dione (25 μM ). Set the detection wavelength to 550nnm, add NADH to start the reaction at room temperature, calculate the reduction rate from the initial linear part of the reaction curve, and convert it by the molar absorption coefficient of cytochrome c (21.1 mM -1 cm -1 ), the result is expressed as μmol reduced cytochrome c / min / mg NQOl. The ability of the compound to produce reactive oxygen can be judged from the change in the amount of cytochrome c. The rate of reactive oxygen production at the enzyme level of the compound is 1143±62 μmol reduced cytochrome c / min / mg NQOl.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a β-lapachone derivative, its preparation method and medical application. The β-lapachone derivative of the present invention is a hybrid of β-lapachone and pyrimidinethione, which has strong anticancer activity, metabolic stability and good selectivity; in vitro cytotoxicity tests show that the compound It has a strong inhibitory effect on test cancer cells; NQO1 activity test shows that this compound is an effective substrate of NQO1, which can generate a large amount of active oxygen through redox reaction cycle mediated by NQO1, induce oxidative stress, and selectively kill It can kill tumor cells and can be further developed as an anti-cancer lead compound targeting NQO1; the preparation method of the invention has the advantages of mild conditions, simple operation and the like.

Description

Technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a β-lapachone derivative, including a preparation method of the compound and its application as an NQO1 targeted anticancer drug. Background technique [0002] Malignant tumors are a serious threat to human health. To overcome and cure malignant tumors has become one of the hotspots of drug research in various countries in the world today. Finding anti-tumor drugs with high efficiency, low toxicity and strong specificity is still the main direction of anti-tumor drug research. Quinone oxidoreductase (NQO1) is an important phase II reaction enzyme in the body. It participates in the metabolism of exogenous substances in the body through de-electron reduction reaction, and has chemical protection and biological activation. Due to the high expression of NQO1 in tumor cells and its biological activation characteristics, it is considered as a potential molecular target for the treatment ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D239/70A61P35/00
CPCC07D239/70
Inventor 武利强王永学
Owner XINXIANG MEDICAL UNIV